Foundation Medicine to Webcast Investor & Analyst Day
August 31 2015 - 6:30AM
Business Wire
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that it
will provide a live video webcast and conference call for its
Investor & Analyst Day on September 15, 2015. At the event,
members of the Foundation Medicine management team will discuss the
company’s five-year strategic vision for transforming cancer care
and the significance of molecular information as a driver of the
company’s future growth and value.
Investor & Analyst Day Webcast and Conference Call
Details
Date: Tuesday, September 15, 2015 Time: 1:00-4:30p.m.
ET Webcast:
The video webcast and slide presentation
accompanying the conference call can be accessed at
www.investors.foundationmedicine.com.
Telephone: Domestic callers, dial 877-633-4016 International
callers, dial 914-495-8535 Access code for both domestic and
international callers: 23905461
Archives of the video and audio webcasts will be available in
the investors section of the company’s website at
investors.foundationmedicine.com. The replays will be available
shortly after the conclusion of the event and will be archived on
the company's website following the call.
About Foundation Medicine
Foundation Medicine (NASDAQ:FMI) is a molecular information
company dedicated to a transformation in cancer care in which
treatment is informed by a deep understanding of the genomic
changes that contribute to each patient's unique cancer. The
company's clinical assays, FoundationOne® for solid tumors and
FoundationOne® Heme for hematologic malignancies and sarcomas,
provide a comprehensive genomic profile to identify the molecular
alterations in a patient's cancer and match them with relevant
targeted therapies and clinical trials. Foundation Medicine's
molecular information platform aims to improve day-to-day care for
patients by serving the needs of clinicians, academic researchers
and drug developers to help advance the science of molecular
medicine in cancer. For more information, please visit
http://www.FoundationMedicine.com or follow Foundation Medicine on
Twitter (@FoundationATCG).
Foundation Medicine® and FoundationOne® are registered
trademarks of Foundation Medicine, Inc.
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995, including, but not limited to, statements regarding the
information to be presented by Foundation Medicine and the ability
of molecular information to drive growth and value for Foundation
Medicine. All such forward-looking statements are based on
management's current expectations of future events and are subject
to a number of risks and uncertainties that could cause actual
results to differ materially and adversely from those set forth in
or implied by such forward-looking statements. These risks and
uncertainties include, but are not limited to, the risks described
under the caption "Risk Factors" in Foundation
Medicine's Quarterly Report on Form 10-Q for the three months
ended June 30, 2015, which is on file with the Securities and
Exchange Commission, as well as other risks detailed in subsequent
filings with the Securities and Exchange Commission. All
information in this press release is as of the date of the release,
and Foundation Medicine undertakes no duty to update this
information unless required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150831005067/en/
Media Contact:Pure Communications, Inc.Dan Budwick,
973-271-6085dan@purecommunicationsinc.comorInvestor
Contacts:Susan Hager,
617-418-2258ir@foundationmedicine.comorMatt Clawson,
949-370-8500matt@purecommunicationsinc.com
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Apr 2023 to Apr 2024